Business Description
Vitro Biopharma Inc
NAICS : 325413
SIC : 2835
Total Employee Number:
2Description
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | -0.49 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -4.99 | |||||
Beneish M-Score | -3.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 218.8 | |||||
3-Year EBITDA Growth Rate | -253.8 | |||||
3-Year FCF Growth Rate | -174.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.16 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 123.74 | |||||
Days Sales Outstanding | 11.14 | |||||
Days Payable | 206.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 82.17 | |||||
Operating Margin % | -153.42 | |||||
Net Margin % | -208.32 | |||||
EBITDA Margin % | -191.62 | |||||
ROE % | -218.09 | |||||
ROA % | -69.63 | |||||
ROIC % | -74.5 | |||||
3-Year ROIIC % | 16.19 | |||||
ROC (Joel Greenblatt) % | -1237.14 | |||||
ROCE % | -84.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 2.44 | |||||
PB Ratio | 2.84 | |||||
EV-to-EBIT | -1.57 | |||||
EV-to-EBITDA | -1.66 | |||||
EV-to-Revenue | 3.18 | |||||
EV-to-FCF | -4.14 | |||||
Earnings Yield (Greenblatt) % | -63.69 | |||||
FCF Yield % | -31.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VTRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vitro Biopharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 6.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitro Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitro Biopharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vitro Biopharma Inc Frequently Asked Questions
What is Vitro Biopharma Inc(VTRO)'s stock price today?
The current price of VTRO is $0.00. The 52 week high of VTRO is $0.00 and 52 week low is $0.00.
When is next earnings date of Vitro Biopharma Inc(VTRO)?
The next earnings date of Vitro Biopharma Inc(VTRO) is .
Does Vitro Biopharma Inc(VTRO) pay dividends? If so, how much?
Vitro Biopharma Inc(VTRO) does not pay dividend.
Guru Commentaries on AMEX:VTRO
No articles.
Press Release
Articles on Vitro Biopharma Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers